TY  - GEN
AU  - Fernández, Oscar
AU  - Izquierdo, Guillermo
AU  - Fernández, Victoria
AU  - Leyva, Laura
AU  - Reyes, Virginia
AU  - Guerrero, Miguel
AU  - León, Antonio
AU  - Arnaiz, Carlos
AU  - Navarro, Guillermo
AU  - Páramo, Maria Dolores
AU  - Cuesta, Antonio De la
AU  - Soria, Bernat
AU  - Hmadcha, Abdelkrim
AU  - Pozo, David
AU  - Fernandez-Montesinos, Rafael
AU  - Leal, Maria
AU  - Ochotorena, Itziar
AU  - Gálvez, Patricia
AU  - Geniz, Maria Angeles
AU  - Barón, Francisco Javier
AU  - Mata, Rosario
AU  - Medina, Cristina
AU  - Caparrós-Escudero, Carlos
AU  - Cardesa, Ana
AU  - Cuende, Natividad
AU  - Research Group Study EudraCT 2008-004015-35
PY  - 2018
DO  - 10.1371/journal.pone.0195891
UR  - http://hdl.handle.net/20.500.12105/17599
AB  - Currently available treatments for secondary progressive multiple sclerosis(SPMS) have limited efficacy and/or safety concerns. Adipose-mesenchymal derived stem cells(AdMSCs) represent a promising option and can be readily obtained using minimally...
LA  - eng
KW  - Adipose Tissue
KW  - Adult
KW  - Feasibility Studies
KW  - Female
KW  - Humans
KW  - Male
KW  - Mesenchymal Stem Cell Transplantation
KW  - Mesenchymal Stem Cells
KW  - Middle Aged
KW  - Multiple Sclerosis, Chronic Progressive
KW  - Treatment Outcome
TI  - Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study.
TY  - research article
ER  -